Actavalon Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Actavalon Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11143
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Actavalon Inc (Actavalon) is an oncology-focused company, which develops small molecule medicines targeting two basic cancer pathways, namely, the p53 tumor suppressor pathway and the aryl hydrocarbon receptor (AhR) pathway. It is developing small molecules that can stabilize the mutant p53 modulators, which restore tumor suppression activity and block gain-of-function by oncogenes in human cancer cells; and selective aryl hydrocarbon receptor modulating agonists (SAhRM) that inhibit estrogen receptor that affects the growth of ER-negative and triple negative breast cancers. The company currently functions out of the JLABS incubator on the Johnson & Johnson Innovation Labs campus in San Diego. Actavalon is headquartered in Corona del Mar, California, the US.

Actavalon Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Actavalon Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Actavalon Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Actavalon Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Actavalon Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Actavalon Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Actavalon Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Actavalon to Raise USD0.3 Million in Venture Financing 10
Actavalon Raises Funds through Venture Financing 11
Actavalon Raises USD0.5 Million in Venture Financing 12
Actavalon Inc – Key Competitors 13
Actavalon Inc – Key Employees 14
Actavalon Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Actavalon Inc, Pharmaceuticals & Healthcare, Key Facts 2
Actavalon Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Actavalon Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Actavalon Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Actavalon Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Actavalon Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Actavalon to Raise USD0.3 Million in Venture Financing 10
Actavalon Raises Funds through Venture Financing 11
Actavalon Raises USD0.5 Million in Venture Financing 12
Actavalon Inc, Key Competitors 13
Actavalon Inc, Key Employees 14

List of Figures
Actavalon Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Actavalon Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Actavalon Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Actavalon Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Actavalon Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Actavalon Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Actavalon Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Actavalon Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Actavalon Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Horizon Pharma Plc (HZNP):製薬・医療:M&Aディール及び事業提携情報
    Summary Horizon Pharma plc (Horizon Pharma) is a pharmaceutical company which develops and commercializes medical products for the treatment of pain, arthritis and inflammatory diseases. It markets medicines through its orphan, primary care and rheumatology business units. The company’s marketed pro …
  • Euro India Fresh Foods Ltd (EIFFL):企業の財務・戦略的SWOT分析
    Euro India Fresh Foods Ltd (EIFFL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • F1 Oncology Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary F1 Oncology Inc (F1 Oncology) is a developer of adoptive cellular therapy candidates. The company develops CAB technology to mitigate the on-target, off-tumor toxicity of Chimeric Antigen Receptor (CAR) T cell therapy. It is developing CAB technology. The company’s drugs are used in rewiring …
  • BNK Petroleum Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    BNK Petroleum Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary BNK Petroleum Inc (BNK Petroleum) is an oil and gas company. The company explores, produces and acquires large hydrocarbon reserves. The company’s project includes Tishomingo Field, Gapowo B-1 well …
  • Novus Therapeutics Inc (NVUS):製薬・医療:M&Aディール及び事業提携情報
    Summary Novus Therapeutics Inc (Tokai Pharma), formerly Tokai Pharmaceuticals Inc is a pharmaceutical company that develops products for ear, nose and throat. The company’s lead products is a nasally-administer, combination drug product and eustachian tube dysfunction, among others. Its galeterone i …
  • Dr. Reddy’s Laboratories Limited:企業の戦略・SWOT・財務情報
    Dr. Reddy's Laboratories Limited - Strategy, SWOT and Corporate Finance Report Summary Dr. Reddy's Laboratories Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • GRP Limited (GRPLTD):企業の財務・戦略的SWOT分析
    GRP Limited (GRPLTD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Empresas Publicas De Medellin ESP:電力:M&Aディール及び事業提携情報
    Summary Empresas Publicas De Medellin ESP (EPM) is a decentralized body, operational under the ownership of Medellin municipality. It generates, transmits, and distributes electricity as well as undertakes gas distribution, wastewater and garbage treatment, and telecommunications services across the …
  • SPAGO Nanomedical AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Spago Nanomedical AB (Spago Nanomedical), formerly Spago Imaging AB is a research and development company that develops nanomedical products for the diagnosis and treatment of cancer. The company offers spagopix, a magnetic resonance imaging contrast agent to improve the visualization of sof …
  • PT PLN (Persero):企業の戦略的SWOT分析
    PT PLN (Persero) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Teva Pharmaceutical Industries Limited:企業のM&A・事業提携・投資動向
    Teva Pharmaceutical Industries Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Teva Pharmaceutical Industries Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed repo …
  • CHDI Foundation Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CHDI Foundation Inc (CHDI) is a non-profit biomedical research organization that discovers and develops drugs for Huntington’s disease. The organization’s activities include identification and validation of therapeutic targets, drug discovery and development, and clinical studies and trials. …
  • Regulus Therapeutics Inc (RGLS):企業の財務・戦略的SWOT分析
    Summary Regulus Therapeutics Inc (Regulus Therapeutics) is a biopharmaceutical company that discovers and develops microRNA based therapeutics. The company provides single stranded oligonucleotides, which are chemically synthesized chains of nucleotides that are mirror images of specific target micr …
  • Green Energy Technology Inc Ltd (3519):電力:M&Aディール及び事業提携情報
    Summary Green Energy Technology Inc Ltd (Green Energy Technology), a subsidiary of Tatung Company is an alternative energy company that manufactures and markets multi-crystalline solar wafers. The company's products include single-crystalline wafer cuttings, thin film photovoltaic modules, multi-cry …
  • TriMas Corporation:企業のM&A・事業提携・投資動向
    TriMas Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's TriMas Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Abbott Laboratories (ABT)-製薬・医療分野:企業M&A・提携分析
    Summary Abbott Laboratories (Abbott) is a healthcare company, which discovers, develops, manufactures, and sells a diversified range of healthcare products including drugs, diagnostics, branded generics, and vascular and nutritional products. The company’s products comprise specialized medicines; me …
  • Cyanotech Corp
    Cyanotech Corp - Strategy, SWOT and Corporate Finance Report Summary Cyanotech Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Philippine National Bank:企業の戦略・SWOT・財務分析
    Philippine National Bank - Strategy, SWOT and Corporate Finance Report Summary Philippine National Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Acorda Therapeutics, Inc.:企業の戦略・SWOT・財務情報
    Acorda Therapeutics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Acorda Therapeutics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Interglobe Aviation Limited:戦略・SWOT・企業財務分析
    Interglobe Aviation Limited - Strategy, SWOT and Corporate Finance Report Summary Interglobe Aviation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆